[Federal Register Volume 76, Number 195 (Friday, October 7, 2011)]
[Notices]
[Page 62447]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-25992]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated May 13, 2011, and published in the Federal Register 
on May 27, 2011, 76 FR 30969, Akorn, Inc., 1222 W. Grand Avenue, 
Decatur, Illinois 62522, made application to the Drug Enforcement 
Administration (DEA) to be registered as an importer of Remifentanil 
(9739), a basic class of controlled substance listed in schedule II.
    The company plans to import Remifentanil in bulk for use in dosage-
form manufacturing.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Akorn, Inc., to import the basic class of controlled 
substance is consistent with the public interest, and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Akorn Inc., to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 
958(a), and in accordance with 21 CFR 1301.34, the above named company 
is granted registration as an importer of the basic class of controlled 
substance listed.

    Dated: September 28, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-25992 Filed 10-6-11; 8:45 am]
BILLING CODE 4410-09-P